Ananthakrishnan, A. N. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12, 205–217 (2015).
Papadakis, K. A. & Targan, S. R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51, 289–298 (2000).
Lodes, M. J. et al. Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 113, 1296–1306 (2004).
Pastor Rojo, O. et al. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm. Bowel Dis. 13, 269–277 (2007).
Gardiner, K. R. et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 36, 897–901 (1995).
Keely, S. et al. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis. Mucosal Immunol. 7, 114–123 (2014).
Mateer, S. W. et al. IL-6 drives neutrophil-mediated pulmonary inflammation associated with bacteremia in murine models of colitis. Am. J. Pathol. 188, 1625–1639 (2018).
Black, H., Mendoza, M. & Murin, S. Thoracic manifestations of inflammatory bowel disease. Chest 131, 524–532 (2007).
Keely, S., Talley, N. J. & Hansbro, P. M. Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol. 5, 7–18 (2012).
Mateer, S. W. et al. Potential mechanisms regulating pulmonary pathology in inflammatory bowel disease. J. Leukoc. Biol. 98, 727–737 (2015).
Herrlinger, K. R. et al. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am. J. Gastroenterol. 97, 377–381 (2002).
Peyrin-Biroulet, L. et al. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin. Gastroenterol. Hepatol. 6, 644–653 (2008).
Liu, Y. et al. Lung and intestine: a specific link in an ulcerative colitis rat model. Gastroenterol. Res. Pract. 2013, 124530 (2013).
Aydin, B. et al. Investigation of pulmonary involvement in inflammatory bowel disease in an experimental model of colitis. Korean J. Intern. Med. 31, 853–859 (2016).
Sethi, S. & Murphy, T. F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355–2365 (2008).
Kc, R., Shukla, S. D., Walters, E. H. & O'Toole, R. F. Temporal upregulation of host surface receptors provides a window of opportunity for bacterial adhesion and disease. Microbiology 163, 421–430 (2017).
Fernandes, E. S. et al. Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression. Br. J. Pharmacol. 146, 209–216 (2005).
Keely, S. et al. Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for gram-positive bacterial translocation across epithelia. Mol. Biol. Cell 21, 538–546 (2010).
Shirasaki, H. et al. Expression of platelet-activating factor receptor mRNA in human and guinea pig lung. Am. J. Respir. Cell Mol. Biol. 10, 533–537 (1994).
Lv, X. X. et al. Cigarette smoke promotes COPD by activating platelet-activating factor receptor and inducing neutrophil autophagic death in mice. Oncotarget 8, 74720–74735 (2017).
Clark, S. E. & Weiser, J. N. Microbial modulation of host immunity with the small molecule phosphorylcholine. Infect. Immun. 81, 392–401 (2013).
Clark, S. E., Snow, J., Li, J., Zola, T. A. & Weiser, J. N. Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog. 8, e1002521 (2012).
O'Toole, R. F., Shukla, S. D. & Walters, E. H. Does upregulated host cell receptor expression provide a link between bacterial adhesion and chronic respiratory disease? J. Transl. Med. 14, 304 (2016).
Hyland, I. K., O'Toole, R. F., Smith, J. A. & Bissember, A. C. Progress in the development of platelet-activating factor receptor (PAFr) antagonists and applications in the treatment of inflammatory diseases. ChemMedChem 13, 1873–1884 (2018).
Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869–877 (1992).
Terashita, Z., Imura, Y., Takatani, M., Tsushima, S. & Nishikawa, K. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. J. Pharmacol. Exp. Ther. 242, 263–268 (1987).
Brinkmann, V. & Zychlinsky, A. Neutrophil extracellular traps: is immunity the second function of chromatin? J. Cell Biol. 198, 773–783 (2012).
Halverson, T. W., Wilton, M., Poon, K. K., Petri, B. & Lewenza, S. DNA is an antimicrobial component of neutrophil extracellular traps. PLoS Pathog. 11, e1004593 (2015).
Cundell, D. R., Gerard, N. P., Gerard, C., Idanpaan-Heikkila, I. & Tuomanen, E. I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377, 435–438 (1995).
Shukla, S. D., Muller, H. K., Latham, R., Sohal, S. S. & Walters, E. H. Platelet-activating factor receptor (PAFr) is upregulated in small airways and alveoli of smokers and COPD patients. Respirology 21, 504–510 (2016).
Radin, J. N. et al. beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect. Immun. 73, 7827–7835 (2005).
Gao, R. et al. C-reactive protein mediating immunopathological lesions: a potential treatment option for severe Influenza A diseases. EBioMedicine 22, 133–142 (2017).
Fillon, S. et al. Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J. Immunol. 177, 6182–6191 (2006).
Knapp, S. et al. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J. Immunol. 180, 3478–3484 (2008).
Okuda, J. et al. Translocation of Pseudomonas aeruginosa from the intestinal tract is mediated by the binding of ExoS to an Na,K-ATPase regulator, FXYD3. Infect. Immun. 78, 4511–4522 (2010).
Patel, N. J. et al. Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am. J Physiol. Gastrointest. Liver Physiol. 292, G134–G142 (2007).
Patel, P. S. & Kearney, J. F. CD36 and platelet-activating factor receptor promote house dust mite allergy development. J. Immunol. 199, 1184–1195 (2017).
Yost, C. C., Weyrich, A. S. & Zimmerman, G. A. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie 92, 692–697 (2010).
Narayana Moorthy, A. et al. In vivo and in vitro studies on the roles of neutrophil extracellular traps during secondary pneumococcal pneumonia after primary pulmonary influenza infection. Front. Immunol. 4, 56 (2013).
Long, M. D., Martin, C., Sandler, R. S. & Kappelman, M. D. Increased risk of pneumonia among patients with inflammatory bowel disease. Am. J. Gastroenterol. 108, 240–248 (2013).
Pinkerton, J. W. et al. Inflammasomes in the lung. Mol. Immunol. 86, 44–55 (2017).
Miller, L. S. et al. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J. Immunol. 179, 6933–6942 (2007).
Gu, Y. et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275, 206–209 (1997).
Ball, C. J. et al. Hydrogen sulfide reduces neutrophil recruitment in hind-limb ischemia-reperfusion injury in an L-selectin and ADAM-17-dependent manner. Plast. Reconstr. Surg. 131, 487–497 (2013).
Zollner, O. et al. L-selectin from human, but not from mouse neutrophils binds directly to E-selectin. J. Cell Biol. 136, 707–716 (1997).
Mitchell, M. J., Lin, K. S. & King, M. R. Fluid shear stress increases neutrophil activation via platelet-activating factor. Biophys. J. 106, 2243–2253 (2014).
Kominsky, D. J. et al. An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling. J. Immunol. 186, 6505–6514 (2011).
Liu, G. et al. Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c. J. Pathol. 243, 510–523 (2017).
Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309–318 (2006).
Marks, E. et al. Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation. Mucosal Immunol. 10, 1224–1236 (2017).
Liu, G et al. Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. JCI Insight 1, e86380 (2016).